Nei dati umani disponibili sono sostanzialmente equivalenti: entrambi aumentano il NAD⁺ ematico in modo affidabile e nessuno dei due ha dimostrato benefici su endpoint clinici solidi. Mancano confronti diretti testa a testa di dimensioni adeguate. In assenza di una differenza provata, la variabile razionale è il costo per grammo.

NMN e NR aumentano davvero il NAD⁺?

Sì, questa parte è solida. I trial umani mostrano coerentemente aumenti del NAD⁺ ematico nell'ordine del +40–100% a seconda di dose e durata. Il punto aperto non è se il NAD⁺ salga, ma se quell'aumento produca un beneficio clinico misurabile.

Quali dosi sono state studiate?

L'NMN è stato studiato per lo più a 250–900 mg/die per 8–24 settimane; l'NR comunemente a 250–1000 mg/die. Dosi più alte non hanno mostrato benefici proporzionalmente maggiori negli studi disponibili.

Entrambi sono risultati ben tollerati nei trial umani condotti finora, senza eventi avversi gravi alle dosi studiate. I dati di sicurezza pluriennali sono però ancora limitati per entrambi.

NR vs NMN: which NAD+ precursor actually makes sense

The question, asked badly

"NMN or NR?" is the question the market pushes you toward, because it assumes one of them wins. In human data the answer is duller and more useful: they are near-twins, and the difference between them is far smaller than the difference between "raises NAD⁺" and "makes you age better".

The right question is: does raising NAD⁺ produce a demonstrated clinical benefit? On that, for both, the answer today is not yet.

What they are, in one line

Both feed the same NAD⁺ salvage pathway:

NR → NMN → NAD⁺

Nicotinamide riboside (NR) is one step earlier; nicotinamide mononucleotide (NMN) is one step later. That is why companies in each camp accuse the other of being "the wrong form": both have a mechanistic argument, neither has the human data that would settle it.

What the human trials show

NAD⁺ goes up. That part is solid. Phase I/II trials of both molecules show consistent increases in blood NAD⁺, typically +40–100% depending on dose and duration. That is a real, reproducible biological effect, not an artefact.

Clinical endpoints do not. What is missing — for both — is the same thing: convincing effects on outcomes that actually matter (physical function, disease incidence, longevity) rather than on the NAD⁺ number itself.

The most-cited NMN trial (PMID 38789831) enrolled 25 older men for 12 weeks: NAD⁺ rose, gait speed improved in a subgroup. Tiny sample, surrogate outcome, short follow-up. On the NR side, safety and bioavailability studies (PMID 29211728) confirm the NAD⁺ rise and good tolerability, but with the same limitation: the endpoint is the biomarker, not health.

The head-to-head that doesn't exist

The weak point of the whole debate is that adequately-sized head-to-head comparisons are missing. There is no large trial randomising people to NMN or NR and measuring who ends up better off. Absent that, any claim that "NMN is superior" or "NR is the right form" is mechanistic argument, not evidence.

What actually differs

	NMN	NR
Raises NAD⁺ in humans	Yes, demonstrated	Yes, demonstrated
Hard clinical endpoints	Not demonstrated	Not demonstrated
Nucleo grade	B	B
Regulatory status	Contested in some markets	More settled as a supplement
Deciding variable	Cost per gram	Cost per gram

The most concrete practical difference is not biological but regulatory and pricing: NMN's status as a supplement has been contested in some markets, while NR sits more comfortably. And price per gram varies far more between brands than the effect varies between the two molecules.

What we don't know

Whether the rise in blood NAD⁺ actually reflects a rise in the tissues that matter.
Whether higher NAD⁺ produces clinical benefit in healthy people.
Whether either form is superior to the other in humans.
What multi-year use does: long-term safety data are missing for both.

Bottom line

They are sold as rivals; in the evidence they are near-twins. Both do something real (raise NAD⁺) and neither has demonstrated the thing that counts (changing how you age). If you take one anyway, the rational variable is cost per gram of a third-party-tested form, not whichever marketing camp shouts loudest.

Some links in this article are affiliate links. We may receive a commission if you purchase through them, at no extra cost to you. This does not influence our ratings.